Ginkgo Bioworks Holdings (DNA) Depreciation & Amortization (CF) (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 13.65% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $56.4 million (down 13.16% YoY), and the FY2025 full-year result was $59.0 million, down 6.39% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $12.8 million, down from $13.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $21.1 million in Q3 2023 and bottomed at $8.9 million in Q3 2022.
• The 5-year median for Depreciation & Amortization (CF) is $14.8 million (2025), against an average of $14.5 million.
• The widest annual swing landed in 2023, when Depreciation & Amortization (CF) surged 136.18%; it then sank 32.12% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $15.7 million in 2022, then fell by 18.06% to $12.8 million in 2023, then grew by 21.93% to $15.7 million in 2024, then decreased by 12.71% to $13.7 million in 2025, then decreased by 6.32% to $12.8 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $12.8 million (Q1 2026), $13.7 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.

Peer Comparison